
Cepheid is dedicated to improving healthcare by pioneering molecular diagnostics that combine speed, accuracy, and flexibility. The company's GeneXpert® systems and Xpert® tests automate highly complex and time-consuming manual procedures, providing A Better Way for institutions of any size to perform world-class PCR testing. Cepheid's broad test portfolio spans respiratory infections, blood virology, women's and sexual health, TB and emerging infectious diseases, healthcare-associated infectious diseases, oncology and human genetics. The company's solutions deliver actionable results where they are needed most – from central laboratories and hospitals to near-patient settings. For more information, visit http://www.cepheid.com. Cepheid is proud to be a part of Danaher. Danaher's science and technology leadership puts Cepheid's solutions at the forefront of the industry, so they can reach more people. Being part of Danaher means we can offer unparalleled breadth and depth of expertise and solutions to our customers. Together with Danaher's other businesses across Biotechnology, Diagnostics, and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every day.
解鎖市場時間軸與訊號動態
全新 市場推廣與公關 活動 — 剛出現 8 個新訊號。
此公司進入各市場的次序 — 由最舊至最新
Field Applications Engineer - Molecular Diagnostics (IVD)
10 active postings
註冊以查看完整訊號動態
Cepheid 的國際擴張與競爭對手的比較
長條顯示所比較各公司之間的相對規模。
欄位5| 公司 | 市場 | 新市場 | 動能 | 活動 | 擴張評分 |
|---|---|---|---|---|---|
Cepheid你 | 9 | 3 | +1200% | 14 | 30 |
Lead Biostatistician, Global Quality, Regulatory, Clinical Affairs
查看招聘Bengaluru East, Karnataka, India · 上星期
Lead Computer Integration Engineer
查看招聘Penang, Penang, Malaysia · 3星期前
Supplier Development & CM Transfer Engineer
查看招聘Penang, Penang, Malaysia · 3星期前
☝️ What if every treatment decision started with better diagnostics?🎤 In this Cepheid Talks podcast episode, Dr. Ephraim Tsalik shares his perspective on the evolving role of diagnostics in clinical decision-making and antimicrobial resistance (AMR). 💫 From advancing innovation to enabling more precise, timely care, this conversation explores how diagnostics can help shape better outcomes for both clinicians and patients.Tune in now: https://ow.ly/44zi50Z7oxA ...
進行中C. difficile Is Not Just Another GI Pathogen — Why Testing Strategy MattersHigh rates of asymptomatic colonization mean that how we test for C. difficile directly impacts diagnosis, treatment decisions, antimicrobial exposure, and stewardship outcomes.🎥 Now available on demand:Watch our global expert webinar to explore:• Colonization vs. true infection• The clinical impact of testing strategy• Diagnostic & antimicrobial stewardship• Practical insights for clinicians and labs👉 Access the on‑dem ...
已結束Hi %FIRSTNAME%At ESCMID Global 2026, experts explored how diagnostic stewardship, smart molecular panels, and the evolving role of metagenomics are shaping more confident clinical decision‑makingIf you couldn’t attend in Munich, you haven’t missed your opportunity. Catch up on the topics belowAccess the recorded symposium and catch up on your own schedule.
已結束解鎖已驗證電郵與直撥電話
免費 · 無需信用卡
關於 Cepheid 業務、市場及增長訊號的快速解答。
